[English] 日本語
Yorodumi- EMDB-27749: Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022 | |||||||||
Map data | cryo-EM structure of SARS-CoV-2 RBD in complex with anti SARS-CoV-2 DARPin (SR22) and two antibody Fabs, S309 and CR3022 | |||||||||
Sample |
| |||||||||
Keywords | DARPins / Anti-SARS-CoV-2 / therapeutics / COVID-19 / VIRAL PROTEIN-IMMUNE SYSTEM complex | |||||||||
| Function / homology | Function and homology informationsymbiont-mediated disruption of host tissue / Maturation of spike protein / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / viral translation / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion ...symbiont-mediated disruption of host tissue / Maturation of spike protein / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / viral translation / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion / membrane fusion / entry receptor-mediated virion attachment to host cell / Attachment and Entry / host cell endoplasmic reticulum-Golgi intermediate compartment membrane / positive regulation of viral entry into host cell / receptor-mediated virion attachment to host cell / host cell surface receptor binding / symbiont-mediated suppression of host innate immune response / receptor ligand activity / endocytosis involved in viral entry into host cell / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / symbiont entry into host cell / virion attachment to host cell / SARS-CoV-2 activates/modulates innate and adaptive immune responses / host cell plasma membrane / virion membrane / identical protein binding / membrane / plasma membrane Similarity search - Function | |||||||||
| Biological species | ![]() Escherichia phage EcSzw-2 (virus) / Homo sapiens (human) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 4.11 Å | |||||||||
Authors | Kwon YD / Gorman J / Kwong PD | |||||||||
| Funding support | United States, 1 items
| |||||||||
Citation | Journal: Nat Chem Biol / Year: 2023Title: A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins. Authors: Vikas Chonira / Young D Kwon / Jason Gorman / James Brett Case / Zhiqiang Ku / Rudo Simeon / Ryan G Casner / Darcy R Harris / Adam S Olia / Tyler Stephens / Lawrence Shapiro / Michael F ...Authors: Vikas Chonira / Young D Kwon / Jason Gorman / James Brett Case / Zhiqiang Ku / Rudo Simeon / Ryan G Casner / Darcy R Harris / Adam S Olia / Tyler Stephens / Lawrence Shapiro / Michael F Bender / Hannah Boyd / I-Ting Teng / Yaroslav Tsybovsky / Florian Krammer / Ningyan Zhang / Michael S Diamond / Peter D Kwong / Zhiqiang An / Zhilei Chen / ![]() Abstract: We report the engineering and selection of two synthetic proteins-FSR16m and FSR22-for the possible treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. FSR16m and ...We report the engineering and selection of two synthetic proteins-FSR16m and FSR22-for the possible treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. FSR16m and FSR22 are trimeric proteins composed of DARPin SR16m or SR22 fused with a T4 foldon. Despite selection by a spike protein from a now historical SARS-CoV-2 strain, FSR16m and FSR22 exhibit broad-spectrum neutralization of SARS-CoV-2 strains, inhibiting authentic B.1.351, B.1.617.2 and BA.1.1 viruses, with respective IC values of 3.4, 2.2 and 7.4 ng ml for FSR16m. Cryo-EM structures revealed that these DARPins recognize a region of the receptor-binding domain (residues 456, 475, 486, 487 and 489) overlapping a critical portion of the angiotensin-converting enzyme 2 (ACE2)-binding surface. K18-hACE2 transgenic mice inoculated with B.1.617.2 and receiving intranasally administered FSR16m showed less weight loss and 10-100-fold lower viral burden in upper and lower respiratory tracts. The strong and broad neutralization potency makes FSR16m and FSR22 promising candidates for the prevention and treatment of infection by SARS-CoV-2. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_27749.map.gz | 59.6 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-27749-v30.xml emd-27749.xml | 22.4 KB 22.4 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_27749_fsc.xml | 8.5 KB | Display | FSC data file |
| Images | emd_27749.png | 88.7 KB | ||
| Filedesc metadata | emd-27749.cif.gz | 6.8 KB | ||
| Others | emd_27749_half_map_1.map.gz emd_27749_half_map_2.map.gz | 59.5 MB 59.5 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-27749 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-27749 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 8dw2MC ![]() 7tyzC ![]() 7tz0C ![]() 8dw3C C: citing same article ( M: atomic model generated by this map |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_27749.map.gz / Format: CCP4 / Size: 64 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | cryo-EM structure of SARS-CoV-2 RBD in complex with anti SARS-CoV-2 DARPin (SR22) and two antibody Fabs, S309 and CR3022 | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.873 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: cryo-EM structure of SARS-CoV-2 RBD in complex with...
| File | emd_27749_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | cryo-EM structure of SARS-CoV-2 RBD in complex with anti SARS-CoV-2 DARPin (SR22) and two antibody Fabs, S309 and CR3022 | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: cryo-EM structure of SARS-CoV-2 RBD in complex with...
| File | emd_27749_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | cryo-EM structure of SARS-CoV-2 RBD in complex with anti SARS-CoV-2 DARPin (SR22) and two antibody Fabs, S309 and CR3022 | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : DARPin SR22 in complex with SARS-CoV-2 RBD and antibody Fabs, S30...
| Entire | Name: DARPin SR22 in complex with SARS-CoV-2 RBD and antibody Fabs, S309 and CR3022 |
|---|---|
| Components |
|
-Supramolecule #1: DARPin SR22 in complex with SARS-CoV-2 RBD and antibody Fabs, S30...
| Supramolecule | Name: DARPin SR22 in complex with SARS-CoV-2 RBD and antibody Fabs, S309 and CR3022 type: complex / ID: 1 / Parent: 0 / Macromolecule list: all Details: DARPin SR22 in complex with SARS-CoV-2 RBD and antibody Fabs, S309 and CR3022 |
|---|---|
| Source (natural) | Organism: ![]() |
-Macromolecule #1: SR22
| Macromolecule | Name: SR22 / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Escherichia phage EcSzw-2 (virus) |
| Molecular weight | Theoretical: 16.428541 KDa |
| Sequence | String: GKKLLEAARA GQDDEVRILM ANGADVNACD PSGITPLHLA ADKGHLEIVE VLLKYGADVN AMDVWGRTPL HLAAFTGHLE IVEVLLKYG ADVNACDLNG YTPLHLAAGR GHLEIVEVLL KNGAGVNAQD KFGKTAFDIS IDNGNEDLAE ILQSSS |
-Macromolecule #2: Spike protein S1
| Macromolecule | Name: Spike protein S1 / type: protein_or_peptide / ID: 2 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 22.100758 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: PNITNLCPFG EVFNATRFAS VYAWNRKRIS NCVADYSVLY NSASFSTFKC YGVSPTKLND LCFTNVYADS FVIRGDEVRQ IAPGQTGKI ADYNYKLPDD FTGCVIAWNS NNLDSKVGGN YNYLYRLFRK SNLKPFERDI STEIYQAGST PCNGVEGFNC Y FPLQSYGF ...String: PNITNLCPFG EVFNATRFAS VYAWNRKRIS NCVADYSVLY NSASFSTFKC YGVSPTKLND LCFTNVYADS FVIRGDEVRQ IAPGQTGKI ADYNYKLPDD FTGCVIAWNS NNLDSKVGGN YNYLYRLFRK SNLKPFERDI STEIYQAGST PCNGVEGFNC Y FPLQSYGF QPTNGVGYQP YRVVVLSFEL LHAPATVCG UniProtKB: Spike glycoprotein |
-Macromolecule #3: Antibody S309 light chain
| Macromolecule | Name: Antibody S309 light chain / type: protein_or_peptide / ID: 3 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 23.204697 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: EIVLTQSPGT LSLSPGERAT LSCRASQTVS STSLAWYQQK PGQAPRLLIY GASSRATGIP DRFSGSGSGT DFTLTISRLE PEDFAVYYC QQHDTSLTFG GGTKVEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS ...String: EIVLTQSPGT LSLSPGERAT LSCRASQTVS STSLAWYQQK PGQAPRLLIY GASSRATGIP DRFSGSGSGT DFTLTISRLE PEDFAVYYC QQHDTSLTFG GGTKVEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS KDSTYSLSST LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRGEC |
-Macromolecule #4: Antibody S309 heavy chain
| Macromolecule | Name: Antibody S309 heavy chain / type: protein_or_peptide / ID: 4 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 24.573471 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: QVQLVQSGAE VKKPGASVKV SCKASGYPFT SYGISWVRQA PGQGLEWMGW ISTYNGNTNY AQKFQGRVTM TTDTSTTTGY MELRRLRSD DTAVYYCARD YTRGAWFGES LIGGFDNWGQ GTLVTVSSAS TKGPSVFPLA PSSKSTSGGT AALGCLVKDY F PEPVTVSW ...String: QVQLVQSGAE VKKPGASVKV SCKASGYPFT SYGISWVRQA PGQGLEWMGW ISTYNGNTNY AQKFQGRVTM TTDTSTTTGY MELRRLRSD DTAVYYCARD YTRGAWFGES LIGGFDNWGQ GTLVTVSSAS TKGPSVFPLA PSSKSTSGGT AALGCLVKDY F PEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SC |
-Macromolecule #5: Antibody CR3022 heavy chain
| Macromolecule | Name: Antibody CR3022 heavy chain / type: protein_or_peptide / ID: 5 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 23.382369 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: TQMQLVQSGT EVKKPGESLK ISCKGSGYGF ITYWIGWVRQ MPGKGLEWMG IIYPGDSETR YSPSFQGQVT ISADKSINTA YLQWSSLKA SDTAIYYCAG GSGISTPMDV WGQGTTVTVA STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW N SGALTSGV ...String: TQMQLVQSGT EVKKPGESLK ISCKGSGYGF ITYWIGWVRQ MPGKGLEWMG IIYPGDSETR YSPSFQGQVT ISADKSINTA YLQWSSLKA SDTAIYYCAG GSGISTPMDV WGQGTTVTVA STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW N SGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSC |
-Macromolecule #6: Antibody CR3022 light chain
| Macromolecule | Name: Antibody CR3022 light chain / type: protein_or_peptide / ID: 6 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 24.289885 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: DIQLTQSPDS LAVSLGERAT INCKSSQSVL YSSINKNYLA WYQQKPGQPP KLLIYWASTR ESGVPDRFSG SGSGTDFTLT ISSLQAEDV AVYYCQQYYS TPYTFGQGTK VEIKRTVAAP SVFIFPPSDE QLKSGTASVV CLLNNFYPRE AKVQWKVDNA L QSGNSQES ...String: DIQLTQSPDS LAVSLGERAT INCKSSQSVL YSSINKNYLA WYQQKPGQPP KLLIYWASTR ESGVPDRFSG SGSGTDFTLT ISSLQAEDV AVYYCQQYYS TPYTFGQGTK VEIKRTVAAP SVFIFPPSDE QLKSGTASVV CLLNNFYPRE AKVQWKVDNA L QSGNSQES VTEQDSKDST YSLSSTLTLS KADYEKHKVY ACEVTHQGLS SPVTKSFNRG EC |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 1 mg/mL |
|---|---|
| Buffer | pH: 7.4 / Details: 10 mM HEPES, 7.4, 150 mM NaCl |
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 95 % / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
| Microscope | FEI TITAN KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Average electron dose: 40.2 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | C2 aperture diameter: 100.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 2.5 µm / Nominal defocus min: 1.25 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
| Initial model | PDB ID: Chain - Source name: PDB / Chain - Initial model type: experimental model |
|---|---|
| Refinement | Space: REAL / Protocol: RIGID BODY FIT / Overall B value: 134 / Target criteria: CC |
| Output model | ![]() PDB-8dw2: |
Movie
Controller
About Yorodumi



Keywords
Homo sapiens (human)
Authors
United States, 1 items
Citation










Z (Sec.)
Y (Row.)
X (Col.)




































FIELD EMISSION GUN


